Why UiPath Stock Is Climbing Today

UiPath, Inc. (NYSE: PATH) shares are trading higher Thursday after the company reported better-than-expected earnings and issued an upbeat third-quarter outlook on Wednesday.

UiPath, Inc. (NYSE:PATH) shares are trading higher Thursday after the company reported better-than-expected earnings and issued an upbeat third-quarter outlook on Wednesday.

The Details:

UiPath reported quarterly earnings of 9 cents per share, beating the consensus estimate of 3 cents and representing an increase of 550% from the same period last year.

The company also reported second-quarter sales of $287.00 million, beating the analyst consensus estimate of $282.14 million and representing an 18.49% increase over sales from the same period last year.

UiPath raised its third-quarter revenue guidance to between $313 million and $318 million and fiscal-year 2024 revenue guidance to between $1.273 billion and $1.278 billion.

Several analysts raised price targets on the stock following the earnings report:

  • Canaccord Genuity analyst Kingsley Crane maintained UiPath with a Buy and raised the price target from $19 to $21.
  • Needham analyst Scott Berg reiterated UiPath with a Buy and maintained $20 price target.
  • RBC Capital analyst Matthew Hedberg maintained UiPath with a Sector Perform and raised the price target from $18 to $19.
  • BMO Capital analyst Keith Bachman maintained UiPath with a Market Perform and raised the price target from $18 to $19.
  • Macquarie analyst Frederick Havemeyer maintained UiPath with an Outperform and raised the price target from $22 to $23.

According to Benzinga Pro, UiPath shares are moving higher on heavy trading volume with more than 18.7 million shares traded, compared to the stock’s 100-day average of just over 8 million shares.

Related News: What’s Going On With PDD Holdings Stock: Report Says TEMU Is “More Dangerous’ Than TikTok

PATH Price Action: According to Benzinga Pro, UiPath shares are trading up more than 10% at $17.99 at the time of publication.

Image: Megan Rexazin from Pixabay

 

 

Total
0
Shares
Related Posts
Read More

US Stocks Edge Higher; Coherus Reports FDA Approval Of UDENYCA ONBODY

U.S. stocks traded slightly higher this morning, with the Dow Jones index gaining more than 20 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.08% to 37,575.13 while the NASDAQ rose 0.17% to 15,099.84. The S&P 500 also rose, gaining, 0.07% to 4,777.93.

BAOS